TRINETRA › Sectors › Chemicals
Camlin Fine Sciences Limited (CAMLINFINE) — share price, P/E and fundamentals
Camlin Fine Sciences Limited (NSE: CAMLINFINE) closed at ₹84.10 on 30 Oct 2026, -54.0% over one year, against a 52-week range of ₹79.10 – ₹204.57.
In the quarter ended 30 Jun 2026 (consolidated, filed 11 Aug 2026) it reported revenue of ₹520 cr and a net loss of ₹32 cr, a -6.1% net margin; revenue grew 22.7% year on year.
On four consecutive filed quarters its trailing P/E is 274.7; since 23 May 2025 its own P/E has ranged from 46.9 to 113.3 (median 69.2), and today's reading is higher than 32% of those 183 trading days.
From the balance sheet dated 31 Mar 2026: return on equity -12.2%, ROCE -5.8%, debt-to-equity 0.64, Piotroski F-score 5 of 9.
Against 43 Chemicals peers on NSE: Net margin higher than 0% of 43 sector peers; PBT margin higher than 0% of 43 sector peers; ROE higher than 2% of 41 sector peers.
Key figures
| Last close | ₹84.10 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -13.5% / -34.0% / -54.0% |
| 52-week low – high | ₹79.10 – ₹204.57 |
| Market capitalisation | ₹1,616 cr |
| Trailing P/E | 274.7 |
| Price / book | 1.55 |
| EV / EBITDA | 26.5 |
| Earnings yield | 0.4% |
| TTM EPS | ₹0.31 |
| TTM net profit | ₹6 cr |
| Quarter revenue | ₹520 cr |
| Quarter net loss | ₹32 cr |
| Net margin | -6.1% |
| Revenue growth (YoY) | +22.7% |
| Profit growth (YoY) | -552.9% |
| Return on equity | -12.2% |
| ROCE | -5.8% |
| Debt / equity | 0.64 |
| Current ratio | 1.27 |
| Free cash flow | ₹25 cr |
| Piotroski F-score | 5 / 9 |
| Average daily turnover (50 days) | ₹4.9 cr |
Against Chemicals peers
| Metric | CAMLINFINE | Peer median | Percentile |
|---|---|---|---|
| Net margin | -6.10 | 9.91 | 0 |
| PBT margin | -6.47 | 13.29 | 0 |
| ROE | -12.18 | 13.64 | 2 |
| ROCE | -5.82 | 16.08 | 0 |
| Debt / equity | 0.64 | 0.23 | 78 |
| Cash conversion | 3.49 | 0.95 | 92 |
| Trailing P/E | 274.66 | 34.59 | 100 |
| P/B | 1.55 | 3.84 | 20 |
Questions
What is the P/E ratio of Camlin Fine Sciences Limited?
Camlin Fine Sciences Limited's trailing P/E is 274.7, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Jun 2026. Since 23 May 2025 its P/E has ranged 46.9–113.3.
What were Camlin Fine Sciences Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Camlin Fine Sciences Limited reported revenue of ₹520 cr and a net loss of ₹32 cr (consolidated), filed with the exchange on 11 Aug 2026.
What is Camlin Fine Sciences Limited's ROE?
Return on equity is -12.2% based on the balance sheet dated 31 Mar 2026.
Does Camlin Fine Sciences Limited have debt?
Debt-to-equity is 0.64 on the balance sheet dated 31 Mar 2026.
What is CAMLINFINE's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, CAMLINFINE traded between ₹79.10 and ₹204.57.
Other Chemicals stocks
- Solar Industries India Limited (SOLARINDS)
- Pidilite Industries Limited (PIDILITIND)
- SRF Limited (SRF)
- Coromandel International Limited (COROMANDEL)
- Linde India Limited (LINDEINDIA)
- Gujarat Fluorochemicals Limited (FLUOROCHEM)
- Navin Fluorine International Limited (NAVINFLUOR)
- Fertilizers and Chemicals Travancore Limited (FACT)
- UPL Limited (UPL)
- Himadri Speciality Chemical Limited (HSCL)
- Aether Industries Limited (AETHER)
- Deepak Nitrite Limited (DEEPAKNTR)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.